Haematological cancer: Prophylactic platelet transfusion is frequently not necessary

Nature Reviews Clinical Oncology

Volumn 10, Issue 8, 2013, Pages 431-432

  Schiffer, Charles A ^a  

^a KARMANOS CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; AUTOLOGOUS STEM CELL TRANSPLANTATION; BLEEDING; GRAM NEGATIVE SEPSIS; HUMAN; INCIDENCE; LEUKEMIA; LYMPHOMA; MULTIPLE MYELOMA; PRIORITY JOURNAL; SHORT SURVEY; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

EID: 84881479236     PISSN: 17594774     EISSN: 17594782     Source Type: Journal    
DOI: 10.1038/nrclinonc.2013.113     Document Type: Short Survey

References (10)

1. Gaydos, L. A., Freireich, E. J. & Mantel, N. The quantitative relation between platelet count and hemorrhage in patients with acute leukemia. N. Engl. J. Med. 266, 905-909 (1962
2. The Trial to Reduce Alloimmunization to Platelets Study Group. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. N. Engl. J. Med. 337, 1861-1869 (1997
3. Heckman, K. D. et al. Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000/microL versus 20,000/microL. J. Clin. Oncol. 15, 1143-1149 (1997
4. Rebulla, P. et al. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. N. Engl. J. Med. 337, 1870-1875 (1997
5. Wandt, H. et al. Safety and cost effectiveness of a 10 × 10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 20 × 10(9)/L trigger: A prospective comparative trial in 105 patients with acute myeloid leukemia. Blood 91, 3601-3606 (1998
6. Schiffer, C. A. et al. Platelet transfusion for patients with cancer: Clinical practice guidelines of the American Society of Clinical Oncology. J. Clin. Oncol. 19, 1519-1538 (2001
7. Stanworth, S. J. et al. A no-prophylaxis platelet-transfusion strategy for hematologic cancers. N. Engl. J. Med. 368, 1771-1780 (2013
8. Wandt, H. et al. Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: An open-label, multicentre, randomised study. Lancet 380, 1309-1316 (2012
9. Wandt, H., Schaefer-Eckart, K., Frank, M., Birkmann, J. & Wilhelm, M. A therapeutic platelet transfusion strategy is safe and feasible in patients after autologous peripheral blood stem cell transplantation. Bone Marrow Transplant. 37, 387-392 (2006
10. Schiffer, C. A. What to do if there is no evidence? The issue of surgical procedures in patients with thrombocytopenia. Transfusion 51, 2262-2264 (2011)